ReviewCNS drugs2020
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Damiano Paolicelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCNS drugs2020
Damiano Paolicelli et al.PubMed ↗Publisher ↗
No numbers read from the abstract.